Management of Unruptured Small Multiple Intracranial Aneurysms in China: A Comparative Effectiveness Analysis Based on Real-World Data

被引:3
|
作者
Chen, Jigang [1 ,2 ]
Tong, Xin [1 ,2 ]
Feng, Xin [3 ]
Peng, Fei [1 ,2 ]
Niu, Hao [1 ,2 ]
Han, Mingyang [4 ]
Liu, Lang [4 ]
Zhao, Yuanli [5 ]
Wang, Daming [3 ]
Pan, Yuesong [6 ,7 ]
Liu, Aihua [1 ,2 ,7 ]
机构
[1] Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing, Peoples R China
[3] Beijing Hosp, Natl Ctr Gerontol, Dept Neurosurg, Beijing, Peoples R China
[4] Cent South Univ, Xiangya Hosp 3, Dept Neurosurg, Changsha, Peoples R China
[5] Peking Univ, Peking Univ Int Hosp, Dept Neurosurg, Beijing, Peoples R China
[6] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[7] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2022年 / 12卷
关键词
multiple intracranial aneurysms; small aneurysm; comparative effectiveness analysis; real-world data; endovascular therapy; ENDOVASCULAR TREATMENT; COST-EFFECTIVENESS; PREVALENCE; MORTALITY; RISK; COILING; STROKE; SEX; AGE;
D O I
10.3389/fneur.2021.736127
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundUnruptured small aneurysms with a size of <7 mm were often followed conservatively. However, it is unknown whether unruptured small multiple intracranial aneurysms (MIAs) are better to be prophylactically treated or conservatively followed. ObjectiveWe aim to compare the effectiveness of different strategies regarding their management. MethodsA decision-analytic Markov model was built over a entire life cycle. The compared strategies include natural history, treat one aneurysm, treat both aneurysms, annual follow-up, biennial follow-up, and follow-up every 5 years. The inputs for the model were obtained from real-world data and related medical literature. Outcomes were measured in terms of quality-adjusted life-years (QALYs). ResultsTreat both aneurysms had the highest effectiveness of 15.36 QALYs and treat one aneurysm had the second-highest effectiveness of 15.11 QALYs. Probabilistic sensitivity analysis with 10,000 iterations showed that treat both aneurysms and treat one aneurysm were optimal in 67.28 and 17.91% of all cases, respectively. One-way and two-way sensitivity analyses showed that the result was sensitive to the proportion of moderate to severe disability after treating two aneurysms, mortality after treating two aneurysms, proportion of moderate to severe disability after treating one aneurysm, and rupture rate of small growing aneurysm. Either treat both aneurysms or treat one aneurysm would be the optimal strategy under most of the circumstances with the variations of these parameters. ConclusionFor patients with small unruptured MIAs, prophylactic coiling was superior to conservative management and at least one aneurysm should be treated.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Line of Therapy Algorithm for Real-World Data Analysis in Multiple Myeloma
    Fajardo, Otto
    Sach-Peltason, Lisa
    Hernandez, Elsa Garcia
    Braun, Franziska
    Weisser, Martin
    Duque, Felipe A. Castro
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 425 - 425
  • [22] Big data and real-world data-based medicine in the management of hypertension
    Mihoko Okada
    Hypertension Research, 2021, 44 : 147 - 153
  • [23] Big data and real-world data-based medicine in the management of hypertension
    Okada, Mihoko
    HYPERTENSION RESEARCH, 2021, 44 (02) : 147 - 153
  • [24] Cost-effectiveness analysis of fosnetupitant in patients receiving cisplatin in Japan: analysis based on real-world data
    Inano, Hiroshi
    Morimoto, Yoshihito
    Kitagawa, Kanata
    Shibuya, Akito
    Nakagomi, Kozue
    Ota, Tomohiro
    Anzo, Yuri
    Miyauchi, Rika
    Shono, Aiko
    Watanabe, Kazuhiro
    Otori, Katsuya
    SUPPORTIVE CARE IN CANCER, 2025, 33 (02)
  • [25] Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritis
    Satoshi Mizutani
    Hitoshi Kodera
    Yoshiko Sato
    Toshihiro Nanki
    Shunji Yoshida
    Hidekata Yasuoka
    Clinical Rheumatology, 2021, 40 : 123 - 132
  • [26] Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritis
    Mizutani, Satoshi
    Kodera, Hitoshi
    Sato, Yoshiko
    Nanki, Toshihiro
    Yoshida, Shunji
    Yasuoka, Hidekata
    CLINICAL RHEUMATOLOGY, 2021, 40 (01) : 123 - 132
  • [27] Real-World Comparative Analysis of Trastuzumab Originator and Biosimilars: Safety, Efficacy, and Cost Effectiveness
    Mamori, Tomoka
    Tanioka, Maki
    Takada, Kenji
    Hamano, Hirofumi
    Tsukioki, Takahiro
    Takahashi, Yuko
    Iwatani, Tsuguo
    Shien, Tadahiko
    Toyooka, Shinichi
    BIODRUGS, 2025, 39 (01) : 131 - 142
  • [28] Comparative Effectiveness of Palliative Chemotherapy in Metastatic Breast Cancer: A Real-World Evidence Analysis
    Feinberg, Bruce
    Kish, Jonathan
    Dokubo, Igoni
    Wojtnek, Jeff
    Gajra, Ajeet
    Lard, Kevin
    ONCOLOGIST, 2020, 25 (04): : 319 - 326
  • [29] EFFECTIVENESS AND SAFETY OF TERIFLUNOMIDE IN PATIENTS WITH MULTIPLE SCLEROSIS: A REAL-WORLD STUDY FROM WEST CHINA HOSPITAL, CHINA
    Wang, J.
    Lang, Y.
    Kong, L.
    Zhang, Y.
    Du, Q.
    Qiu, Y.
    Zhou, H.
    VALUE IN HEALTH, 2021, 24 : S198 - S198
  • [30] Comparative effectiveness of lenalidomide/dexamethasone-based triplet regimens for treatment of relapsed and/or refractory multiple myeloma in the United States: An analysis of real-world electronic health records data
    Ailawadhi, Sikander
    Cheng, Mu
    Cherepanov, Dasha
    Dersarkissian, Maral
    Stull, Dawn Marie
    Hilts, Annalise
    Chun, Justin
    Duh, Mei Sheng
    Sanchez, Larysa
    CURRENT PROBLEMS IN CANCER, 2024, 50